Computational gene network analysis reveals TNF-induced angiogenesis

BMC Systems Biology

Volumn 6, Issue SUPPL.2, 2012, Pages

  Ogami, Kentaro ^a   Yamaguchi, Rui ^a   Imoto, Seiya ^a   Tamada, Yoshinori ^a   Araki, Hiromitsu ^b   Print, Cristin ^b   Miyano, Satoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; BAYES THEOREM; BIOLOGY; CLUSTER ANALYSIS; DRUG EFFECT; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; METHODOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

BAYES THEOREM; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE REGULATORY NETWORKS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84878640877     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-S2-S12     Document Type: Article

References (22)

1. Wellbrock J, Fiedler W. Clinical experience with anti angiogenic therapy in leukemia. Curr Cancer Drug Targets 2011, 11(9):1053-1068. 10.2174/156800911798073078, 21999626.
2. Konisti S, Kiriakidis S, Paleolog EM. Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 2012, 8(3):153-162. 10.1038/nrrheum.2011.205, 22293762.
3. Eleutherakis-Papaiakovou V, Bamias A, Dimopoulos MA. Thalidomide in cancer medicine. Ann Oncol 2004, 15(8):1151-1160. 10.1093/annonc/mdh300, 15277253.
4. Hideshima T, Chauhan D, Shima Y, Raje N, Davies FE, Tai YT, Treon SP, Lin B, Schlossman RL, Richardson P, Muller G, Stirling DI, Anderson KC. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood 2000, 96(9):2943-2950.
5. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994, 91(9):4082-4085. 10.1073/pnas.91.9.4082, 43727, 7513432.
6. Baumgartner SW. Tumor necrosis factor inactivation in the management of rheumatoid arthritis. South Med J 2000, 93(8):753-759.
7. Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, Sood AK. Stress effects on FosB-and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem 2010, 285(46):35462-35470. 10.1074/jbc.M110.109579, 2975170, 20826776.
8. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biology 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
9. Tamada Y, Shimamura T, Yamaguchi R, Imoto S, Nagasaki M, Miyano S. SiGN: Large-scale gene network estimation environment for high performance computing. Genome Informatics 2011, 25(1):40-52.
10. http://sign.hgc.jp/signbn/index.html
11. https://supcom.hgc.jp/english/
12. https://cionline.hgc.jp/cionlineserver/apps/usersman/main
13. Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 2012, 1(1):58-70. 3378312, 22724089.
14. Rokavec M, Wu W, Luo JL. IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell 2012, 45(6):777-789. 10.1016/j.molcel.2012.01.015, 22364742.
15. Wang L, Hurley DG, Watkins W, Araki H, Tamada Y, Muthukaruppan A, Ranjard L, Derkac E, Imoto S, Miyano S, Crampin EJ, Print CG. Cell cycle gene networks are associated with melanoma prognosis. PLoS One 2012, 7(4):e34247. 10.1371/journal.pone.0034247, 3335030, 22536322.
16. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signalling module: temporal control and selective gene activation. Science 2002, 298(5596):1241-1245. 10.1126/science.1071914, 12424381.
17. Hurley D, Araki H, Tamada Y, Dunmore Y, Sanders D, Humphreys S, Affara M, Imoto S, Yasuda K, Tomiyasu Y, Tashiro K, Savoie C, Cho V, Smith S, Kuhara S, Miyano S, Charnock-Jones DS, Crampin E, Print C. Gene network inference and visualisation tools for biologists: Application to new human transcriptome datasets. Nucleic Acids Research 2011, 40(6):2377-2398. 3315333, 22121215.
18. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997, 17(7):4015-4023. 232254, 9199336.
19. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993, 90(21):10193-10197. 10.1073/pnas.90.21.10193, 47740, 8234276.
20. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003, 170(6):3369-3376.
21. Duval H, Harris M, Li J, Johnson N, Print CG. New insights into the function and regulation of vascular endothelial cell apoptosis. Angiogenesis 2003, 6(3):171-183.
22. Perrot-Applanat M, Vacher S, Toullec A, Pelaez I, Velasco G, Cormier F, Saad Hel S, Lidereau R, Baud V, Bièche I. Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. PLoS One 2011, 6(7):e21589. 10.1371/journal.pone.0021589, 3130773, 21754991.